Cardiovascular Diseases Therapeutics Market in Asia-Pacific to 2019 - Market Trends, Regulations and Competitive Landscape
GBI Research has released its pharmaceutical research, "Cardiovascular Diseases Therapeutics Market in Asia-Pacific to 2019 - Promising Pipeline Drugs to Offset Revenue Decline from Generic Erosion and Off-Label Use", which provides insights into three cardiovascular therapeutic indications in in Asia-Pacific (APAC) markets of India, China, Japan and Australia. The report provides an in-depth analysis of the cardiovascular therapeutic indications, namely heart failure, myocardial infarction (MI), acute coronary syndrome (ACS). The report provides an estimation of market size for 2012, along...
View full press release